✦ LIBER ✦

Controversies in the management of Parkinson's disease

✍ Scribed by Dr. Donald B. Calne; Urpo K. Rinne

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 299 KB
Volume: 1
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870010301

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the “gold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ Manfred Gerlach; Heinz Reichmann; Peter Riederer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.

Current controversies: Levodopa in the t

Current controversies: Levodopa in the treatment of Parkinson's disease

✍ Jagdish C. Sharma; M. Vassallo; I.N. Ross 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Reichmann, and Riederer and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in the September, 2004 issue of __Movement__ Disorders (2004) 19 (9) 997–1005.

Reply: Levodopa in the treatment of Park

Reply: Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract The original articles to which this Letter refers have published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Rei

Major nutritional issues in the manageme

Major nutritional issues in the management of Parkinson's disease

✍ Michela Barichella; Emanuele Cereda; Gianni Pezzoli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 1 views

## Abstract As with other neurodegenerative diseases, neurologic and nutritional elements may interact affecting each other in Parkinson's disease (PD). However, the long‐term effects of such interactions on prognosis and outcome have not been given much attention and are poorly addressed by curren